alpha-aminopyridine has been researched along with Vascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pérez, M; Chioua, M; Gandía, L; García, AG; González-Lafuente, L; López, MG; Marco-Contelles, J; Ríos, Cde L; Roda, JM; Romero, A; Samadi, A; Soriano, E; Villarroya, M | 1 |
| Aouadi, M; Bhattacharya, SK; Buckbinder, L; Cooper, MP; Cortes, C; Czech, MP; Danai, LV; Fitzgibbons, TP; Hagan, N; Matevossian, A; Menendez, LG; Roth Flach, RJ; Skoura, A; Vangala, P; Yawe, JC; Zheng, W | 1 |
| Germer, CT; Roewer, N; Schick, MA; Schlegel, N; Waschke, J; Wollborn, J; Wunder, C | 1 |
3 other study(ies) available for alpha-aminopyridine and Vascular Diseases
| Article | Year |
|---|---|
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyri
Topics: Acetylcholinesterase; Alzheimer Disease; Aminopyridines; Animals; Butyrylcholinesterase; Cell Line, Tumor; Cholinergic Agents; Cholinesterase Inhibitors; Electrophorus; Horses; Humans; Models, Molecular; Neurons; Neuroprotective Agents; Nitriles; Pyridines; Vascular Diseases | 2010 |
Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis.
Topics: Aminopyridines; Animals; Apolipoproteins E; Atherosclerosis; Endothelial Cells; Gene Expression Regulation; Inflammation; Macrophages; Male; Mice; Mice, Knockout; NF-kappa B; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Receptors, LDL; Vascular Diseases | 2015 |
Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation.
Topics: Aminopyridines; Animals; Benzamides; Capillaries; Capillary Permeability; Cyclic AMP; Cyclopropanes; Endothelium, Vascular; Inflammation; Lipopolysaccharides; Male; Microcirculation; Phosphodiesterase 4 Inhibitors; Rats; Rats, Sprague-Dawley; Rolipram; Vascular Diseases | 2012 |